Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 août 2015 16h01 HE | Source: CareDx, Inc.

CareDx, Inc. Reports Second Quarter 2015 Financial Results

BRISBANE, Calif., Aug. 10, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
06 août 2015 09h00 HE | Source: CareDx, Inc.

CareDx and DNAnexus Collaborate on Cloud-Based Genomics Platform for Cell-Free DNA

BRISBANE, Calif. and MOUNTAIN VIEW Calif., Aug. 6, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of...
27 juil. 2015 16h01 HE | Source: CareDx, Inc.

CareDx to Release Second Quarter 2015 Financial Results and Host Conference Call on August 10, 2015

BRISBANE, Calif., July 27, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically...
03 juin 2015 06h00 HE | Source: CareDx, Inc.

CareDx and Horizon Discovery Group Enter into a Collaboration for Development of Cell-Free DNA Reference Standards

BRISBANE, Calif. and CAMBRIDGE, United Kingdom, June 3, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization...
27 mai 2015 16h06 HE | Source: CareDx, Inc.

CareDx to Present at Jefferies and JMP Investor Conferences in June

BRISBANE, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
12 mai 2015 16h05 HE | Source: CareDx, Inc.

CareDx, Inc. Reports First Quarter 2015 Financial Results

Quarterly Revenue Growth of 22% Year Over Year Cell-Free DNA Technology Advances With the Release of Clinical Data and the Start of a Clinical Trial BRISBANE, Calif., May 12, 2015 (GLOBE...
04 mai 2015 06h30 HE | Source: CareDx, Inc.

CareDx Announces First Patients Enrolled in Largest-Ever Multicenter Kidney Transplant Study Using Cell-Free DNA Technology

BRISBANE, Calif., May 4, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value,...
30 avr. 2015 16h01 HE | Source: CareDx, Inc.

Key Opinion Leaders to Present Data on Cell-Free DNA (cfDNA) Biomarker in Transplant Recipients at 2015 American Transplant Congress

BRISBANE, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
30 avr. 2015 16h01 HE | Source: CareDx, Inc.

CareDx to Release First Quarter 2015 Financial Results and Host Conference Call on May 12, 2015

BRISBANE, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
16 avr. 2015 11h00 HE | Source: CareDx, Inc.

CareDx Cell-Free DNA (cfDNA) Biomarker in Combination With AlloMap(R) Increases Accuracy of Identification of Rejection in Heart Transplant Recipients

BRISBANE, Calif. and NICE, France, April 16, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically...

Page précédente